" /> Methemoglobinemia due to deficiency of methemoglobin reductase - CISMeF





Preferred Label : Methemoglobinemia due to deficiency of methemoglobin reductase;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Nadh-dependent methemoglobin reductase deficiency; Nadh-cytochrome b5 reductase deficiency; Methemoglobinemia, congenital, autosomal recessive;

Included titles and symbols : Methemoglobinemia, type I; Methemoglobinemia, type II; Nadh-cytochrome b5 reductase deficiency, type I; Nadh-cytochrome b5 reductase deficiency, type II;

Description : Methemoglobinemia due to NADH-cytochrome b5 reductase deficiency is an autosomal recessive disorder characterized clinically by decreased oxygen carrying capacity of the blood, with resultant cyanosis and hypoxia (review by Percy and Lappin, 2008). There are 2 types of methemoglobin reductase deficiency. In type I, the defect affects the soluble form of the enzyme, is restricted to red blood cells, and causes well-tolerated methemoglobinemia. In type II, the defect affects both the soluble and microsomal forms of the enzyme and is thus generalized, affecting red cells, leukocytes, and all body tissues. Type II methemoglobinemia is associated with mental deficiency and other neurologic symptoms. The neurologic symptoms may be related to the major role played by the cytochrome b5 system in the desaturation of fatty acids (Vives-Corrons et al., 1978; Kaplan et al., 1979).;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the cytochrome b5 reductase 3 gene (CYB5R3, 613213.0001);

Laboratory abnormalities : NADH-cytochrome b(5) reductase deficiency;

Prefixed ID : #250800;

Details


You can consult :


Nous contacter.
08/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.